Biography
Michael Beresford is the Brough Chair, Professor of Child Health at University of Liverpool and Honorary Consultant Paediatric Rheumatologist at Alder Hey Children’s NHS Foundation Trust. He is Director of the UK’s first and only ‘Experimental Arthritis Treatment Centre for Children’ and Clinical Director of the NIHR Alder Hey Clinical Research Facility for Experimental Medicine. He is also Specialty Cluster Lead for the NIHR Clinical Research Network responsible for the National Specialties of Children, Reproductive & Childbirth, Musculoskeletal, Ophthalmology and Haematology. He is responsible across the NIHR CRN for ‘Therapeutics, Stratified/Personalized Medicine and Clinical Pharmacology’.
He is Executive member of the Paediatric Rheumatology European Society (PRES), Chairs the PRES SLE Working Party and UK JSLE Study Group, and leads an internationally renowned Childhood Lupus translational research programme as part of the UK’s only Centre of Excellence for Childhood Lupus.
Professor Beresford has an international reputation in Paediatric Rheumatology, including expertise in clinical trials and translational science and is co-investigator and work stream lead on several MRC-funded Stratified Medicine programmes including the MRC Stratified Medicine Program: ‘CLUSTER’ (Childhood arthritis and its associated uveitis: stratification through endotypes and mechanism to deliver benefit; the CLUSTER Consortium).
Professor Beresford’s research interests include: clinical trials in paediatric rheumatic diseases; interaction of the innate and adaptive immune systems in lupus pathogenesis; discovery of novel therapeutic targets for translation into safer, more effective treatments.
Expertise in support of EATC for children
- Clinical paediatric rheumatology
- Clinical trials in JIA and JIA-uveitis
- Disease mechanisms in JSLE
- Development of novel therapeutic targets
Back to: Experimental Arthritis Treatment Centre for Children